Citation Impact
Citing Papers
The clinical symptoms of Parkinson's disease
2016 Standout
What contributes to depression in Parkinson's disease?
2001
Astrocytes: biology and pathology
2009 Standout
Progression of parkinsonism in multiple system atrophy
2005
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table
2004
Glutamate receptor ion channels
2005 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Parkinson's disease
2021 Standout
The cerebellum and cognition
2018 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
1998 StandoutNobel
Glutamate uptake
2001 Standout
Parkinson's disease with late Pick's dementia
2001
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
1996 Standout
What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration
2003
Multiple System Atrophy: A Sporadic Synucleinopathy
1999
Parkinson's disease: clinical features and diagnosis
2008 Standout
Accuracy of the Clinical Diagnosis of Corticobasal Degeneration
1997
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
2004
A systematic review of prevalence studies of depression in Parkinson's disease
2007 Standout
Amyotrophic lateral sclerosis
2011 Standout
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination
1998
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Molecular genetics of spinocerebellar ataxia type 8 (SCA8)
2003
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
2008 Standout
What Is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy?
1997
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
The Rate of Cognitive Decline in Parkinson Disease
2004
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
2011
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Machado-Joseph Disease: from first descriptions to new perspectives
2011
Diagnostic Criteria for Parkinson Disease
1999 Standout
Prevalence and Characteristics of Dementia in Parkinson Disease
2003 Standout
Consensus statement on the diagnosis of multiple system atrophy
1998
Course of cognitive decline in Parkinson's disease: A meta-analysis
2007
Multiple system atrophy: A review of 203 pathologically proven cases
1997
Striatonigral Degeneration: Iron Deposition in Putamen Correlates with the Slit-like Void Signal of Magnetic Resonance Imaging
1994
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
1996 Standout
Parkinson's Disease
1998 Standout
Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging
2003
Long noncoding RNAs and human disease
2011 Standout
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Apraxia in movement disorders
2005
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography
1999
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
1997 Standout
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
1997 StandoutNobel
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
1992
Excitotoxicity and motor neurone disease: A review of the evidence
1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Consensus statement on the diagnosis of multiple system atrophy
1999
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Management of Parkinson's disease: An evidence-based review
2002
Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature
2017
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
The PRIAMO study: active sexual life is associated with better motor and non‐motor outcomes in men with early Parkinson's disease
2019
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
2014 StandoutNobel
Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study
2005
Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.
1995
Clinical usefulness of magnetic resonance imaging in multiple system atrophy
1998
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
2009 Standout
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Neuropsychological picture of 33 spinocerebellar ataxia cases
2011
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
CATEGORY SPECIFIC SEMANTIC IMPAIRMENTS
1984 Standout
A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease
2000
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Works of V. Fetoni being referenced
Progression of motor and cognitive impairment in Parkinson's disease
1995
Cabergoline in Parkinson's disease complicated by motor fluctuations
1996
MRI in corticobasal degeneration
1995
Variations in Axial, Proximal, and Distal Motor Response to L-Dopa in Multisystem Atrophy and Parkinsonʼs Disease
1997
Multiple system atrophy. Clinical and MR observations on 42 cases
1993
Response to L-DOPA in Multiple System Atrophy
1993
Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis
1989
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy
1999
The relevance of gender in Parkinson’s disease: a review
2017
Molecular Genetics of Hereditary Spinocerebellar Ataxia
2004
Spinocerebellar ataxia type 17 (SCA17): Oculomotor phenotype and clinical characterization of 15 Italian patients
2007
Cognitive Dysfunction and Impaired Organization of Complex Motility in Degenerative Parkinsonian Syndromes
1998